IMA issued a white paper on stent price control and opposed Inclusion of all stents under price control by NPPA. IMA raised several technical objection points for price control. In an interview on a popular TV channel, National President IMA suggested it was better to leave the price to market dynamics and suggested this be implemented in the government sector.

Please share your views in this regard.